3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Acute Onset Vascular Dementia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amthauer, H; Felix, R; Gutberlet, M; Kivi, A; Klaffke, S; Klostermann, F; Kupsch, A; Marzinzik, F; Plotkin, M; Quill, S | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Acute Onset Vascular Dementia
Article | Year |
---|---|
Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases.
Topics: Aged; Aged, 80 and over; Benzamides; Carbon Radioisotopes; Cerebrovascular Circulation; Dementia, Vascular; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2005 |